One study has found that VEGFR1 expression on patient breast cancer tumor cells, following neoadjuvant chemotherapy, is correlated with increased survival; in fact, the number of tumors expressing VEGFR1 increased by nearly 25% following therapy 94. The gene discussed is FLT1; the disease is breast cancer.